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Abstract
Background: Recent studies in Southeast Asia have demonstrated substantial zoonotic transmission of Plasmodium
knowlesi to humans. Microscopically, P. knowlesi exhibits several stage-dependent morphological similarities to P. malariae
and P. falciparum. These similarities often lead to misdiagnosis of P. knowlesi as either P. malariae or P. falciparum and PCR-
based molecular diagnostic tests are required to accurately detect P. knowlesi in humans. The most commonly used PCR test
has been found to give false positive results, especially with a proportion of P. vivax isolates. To address the need for more
sensitive and specific diagnostic tests for the accurate diagnosis of P. knowlesi, we report development of a new single-step
PCR assay that uses novel genomic targets to accurately detect this infection.
Methodology and Significant Findings: We have developed a bioinformatics approach to search the available malaria
parasite genome database for the identification of suitable DNA sequences relevant for molecular diagnostic tests. Using
this approach, we have identified multi-copy DNA sequences distributed in the P. knowlesi genome. We designed and
tested several novel primers specific to new target sequences in a single-tube, non-nested PCR assay and identified one set
of primers that accurately detects P. knowlesi. We show that this primer set has 100% specificity for the detection of P.
knowlesi using three different strains (Nuri, H, and Hackeri), and one human case of malaria caused by P. knowlesi. This test
did not show cross reactivity with any of the four human malaria parasite species including 11 different strains of P. vivax as
well as 5 additional species of simian malaria parasites.
Conclusions: The new PCR assay based on novel P. knowlesi genomic sequence targets was able to accurately detect P.
knowlesi. Additional laboratory and field-based testing of this assay will be necessary to further validate its utility for clinical
diagnosis of P. knowlesi.
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Introduction
Until recently, only four Plasmodium species, P. falciparum, P.
vivax, P. malariae and P. ovale, were thought to contribute to human
malaria infections. However, recent studies in Southeast Asia have
shown zoonotic transmission of P. knowlesi to humans [1–15]. P.
knowlesi is a parasite species that readily infects Old World
monkeys, reviewed in [16]. The natural hosts of this simian
malaria parasite are the long-tailed (Macaca facsicularis) and pig-
tailed (M. nemestrina) macaque monkeys and langurs (Presbytis sp.)
[17–19] that are distributed throughout much of Southeast Asia.
The transmission of P. knowlesi is closely related to its vector
species in the Anopheles leucophyrus group, which are forest-dwelling
mosquitoes found in forest canopies or on forest fringes [8–10].
Indeed, many of the reported human P. knowlesi cases were found
either near forests or as imported cases from individuals known to
have visited the forests [20–22]. To date, no human-to-human
transmission has been documented and chloroquine is effective in
treating these infections [3]. P. knowlesi has a 24-hour asexual life
cycle [23], the shortest observed, thus far, for human-infecting
parasites. This short cycle can lead to rapid increases in
parasitemia and can lead to severe disease including fatalities as
reported in recent studies [1,2]. Given these observations, human
infections with P. knowlesi require immediate and appropriate
treatment, which in turn depends upon a prompt and accurate
diagnosis.
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logical similarities to P. malariae and P. falciparum [3,24]. These
similarities have contributed to misdiagnosis of P. knowlesi as P.
malariae [1,3] or P. falciparum. For example, a study in the Kapit
Division of Malaysian Borneo, found that 58% of previously
diagnosed P. malariae cases were actually P. knowlesi infections [3].
In this study by Singh et al., [3] a nested PCR-based diagnostic test
for the detection of P. knowlesi 18S ribosomal RNA genes was
developed and has been used in numerous subsequent studies
[1,7–9,25–27]. However, this test was recently noted to cross-react
with P. vivax leading to potential false positive results for a small
proportion of human clinical P. vivax samples [26]. This
observation was confirmed by results from our laboratory, in
which cross reactivity with P. vivax and other simian Plasmodium
species (P. cynomolgi, P. inui, P. coatneyi, and P. hylobati) was observed
(Figure 1). These findings have raised some concern about the
actual extent of the reported P. knowlesi cases [28,29], although P.
knowlesi DNA from some of the diagnosed cases was sequenced in
order to confirm the presence of this parasite [7–9]. Therefore,
development of an improved molecular diagnostic test is critical
not only for the proper diagnosis of human infections, but also for
estimating the true burden of P. knowlesi infection in human
populations.
Imwong et al. recently reported a nested PCR assay with 100%
specificity for detecting P. knowlesi [26]. In addition, a loop
mediated isothermal amplification (LAMP) method designed to
detect the beta tubulin gene of P. knowlesi [30] and two real-time
PCR assays [31,32] have been reported to be highly specific for
the detection of P. knowlesi. We recently reported on the use of a
bioinformatics approach to mine available genome data and
identify suitable DNA sequences that are highly specific to a given
species of malaria parasite [33]. Using this approach, we have
identified highly-specific, multi-copy sequences from the P. knowlesi
genome and designed novel primers that can be used in a single-
tube, non-nested PCR diagnostic test. We have identified one set
of primers that has high specificity (100%) for the detection of P.
knowlesi at a low level of parasitemia (1 parasite per uL).
Methods
Plasmodium parasites and clinical samples
Different Plasmodium species available in our laboratories were
utilized to test the specificity of the novel P. knowlesi primers: P.
falciparum (3D7 clone), P. vivax (South Vietnam IV), P. malariae
(Uganda I), P. ovale (Nigeria I), and 11 other P. vivax strains (Ong,
Thai III, India VII, Honduras I, Salvador II, Panama I, Chesson,
Vietnam IV, Pakchong, Mauritania I and Indonesia XIX). Three P.
knowlesi isolates (Nuri, H, and Hackeri) and 5 simian malaria
parasites (P. simiovale, P. inui, P. cynomolgi, P. hylobati and P. coatneyi)
available in the CDC laboratory collection were included. In
addition, DNA from 52 clinical samples, previously diagnosed using
a nested PCR method [34] (14 P. falciparum,9P. vivax,1P. malariae,
12 P. ovale, 2 P. falciparum/P. malariae, 1 P. vivax/P. ovale, 2P .
falciparum/P. ovale mixed infections, 1 P. knowlesi and 10 malaria
negative samples), were tested in a blinded manner. The P. knowlesi
sample was acquired from a traveler who returned infected after a
trip to the Philippines in 2008, representing the first recognized case
of imported simian malaria in several decades in the United States
[35]. These clinical samples were obtained from the CDC molecular
diagnostic parasitology reference laboratory (Dr. A. da Silva).
DNA extraction
The QIAamp DNA Mini Kit (QIAGEN, Valencia, CA-(Qiagen
method) was used to isolate DNA from the different Plasmodium
parasites following the manufacturer’s protocol. The DNA was
aliquoted and stored at 220uC until used in the experiments.
Figure 1. 18S ribosomal RNA gene based P. knowlesi primer cross-reacts with P. vivax and other simian-infecting malaria species.
Published 18S ribosomal RNA gene based P. knowlesi primers [3] were used to test 5 different simian-infecting malaria parasite species (P. simiovale, P.
inui, P. cynomolgi, P. hylobati and P. coatneyi) including 3 different P. knowlesi isolates (A) and 11 P. vivax strains (B). A no template control (NTC) was
included. Cross reactivity was observed with some of the simian malaria parasites and some P. vivax strains.
doi:10.1371/journal.pone.0031848.g001
Novel PCR for Plasmodium knowlesi Detection
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e31848Novel P. knowlesi target validation
Assembled genome sequence data for P. knowlesi was obtained
from PlasmoDB (http://plasmodb.org/plasmo/; release 5.5). The
sequence candidates were selected as previously described [33].
Briefly, genome sequence data were mined for repetitive content.
The identified repetitive sequences were screened for a number of
properties that would negate their utility as PCR targets, such as
tandem repeats and human or artificial (vector) sequence
similarity. Repeats passing these screens were evaluated for
species-specificity. The copy number of candidate targets satisfying
a length requirement of 300 bp was determined, and targets with
greater than 5 copies/genome were further considered as potential
diagnostic targets. Primers were designed manually to the
candidate targets and screened for GC-content, melting temper-
ature, secondary structure, and primer-dimer forming potential.
Primer pairs were optimized by means of gradient PCR using P.
knowlesi DNA (strain H) to determine the optimum annealing
temperature, primer concentration (concentrations from 0.25 mM
to 1.0 mM were tested) and MgCl2 concentrations (2.0mM–
4.0mM were tested). Primers were then tested for P. knowlesi
specificity and sensitivity.
Specificity assay
Primers that passed the initial validation tests were further tested for
specificity using 11 P. vivax strains and different simian Plasmodium
species and strains. DNAs from 52 clinical samples were tested blindly.
PCR assays
All PCR tests were completed on a BioRad iCycler (BioRad,
Hercules, CA). Nested PCR for P. knowlesi was performed with
primers and cycling conditions as described before [3]. The
confirmatory nested PCR used to test the 52 clinical samples was
as previously described [34]. The PCR amplified material was
analyzed using gel electrophoresis (2% agarose gel) to visualize the
bands of appropriate size. Amplification of P. knowlesi using the
novel primers was performed in a 25 ml reaction containing 16
Taq Buffer (containing 10mM Tris-HCl, 50mM KCl, 1.5mM
MgCl2) , 200 mM each dNTP, 1.25 units of Taq DNA Polymerase
(all from New England Biolabs, Ipswich MA, USA), 250nM each
oligonucleotide primer, and 1 ml of DNA template. The sequences
of the final oligonucleotide primer set (Pkr140-5) selected for P.
knowlesi detection are shown in Table 1. Reactions were performed
under the following cycling parameters: initial denaturation at
95uC for 2 minutes, and then 35 cycles of 95uC for 30 seconds,
57uC for 30 seconds, and 72uC for 45 seconds, followed by final
extension at 72uC for 5 minutes. Ten mL of PCR products were
visualized by gel electrophoresis on a 2% agarose gel.
Limits of detection of the PCR amplification using the
new primers
The analytical sensitivity of the assay was determined using a
well-quantified P. knowlesi H strain sample obtained from an
infected monkey. The WHO recommended protocol for the
preparation of standards for use in the quality control of rapid
diagnostic tests (http://www.wpro.who.int/sites/rdt/using_rdts/
qa/lot_testing.htm) was used to prepare the parasite standard for
this study. The P. knowlesi parasites were at either the ring or early
trophozoite stages of development when the sample was utilized.
The percent parasitemia of the infected monkey was determined
by three expert microscopists by counting the number of infected
erythrocytes in 10,000 erythrocytes. The total number of
erythrocytes per microliter was determined through use of a
coulter counter and the number of parasites/mL was then
determined from the total number of RBCs/mL. The resulting
parasitemia was determined to be 225,000 parasites/mL. This
standard sample was then diluted from the initial parasitemia to
100,000 parasites/mL using uninfected blood and then serial
diluted ten-fold to 1p/mL using a 250 mL volume. DNA was
extracted from each dilution point using 200 mL of sample. These
diluted samples were used to test the limits of detection of the
previously described primers [3] and the novel Pkr140-5 primer
set described here.
Results
Primer Design
Four genomic sequence targets passed the in silico tests and were
selected for validation. A total of 14 primers were designed to these
targets and empirically tested in conventional PCR amplification
assays using P. knowlesi-H DNA sample. Of the 14 primers
designed, three sets (Pkr140-3, Pkr140-4 and Pkr140-5), all of
which recognize the Pkr140 repeat sequence, were selected for
further evaluation as they correctly amplified P. knowlesi as
evidenced by clean, intense, single bands of the expected size.
The Pkr140 sequence exists in 7 copies in the available P. knowlesi
genome sequence.
Tests for assay specificity
The three Pkr140 primer sets were tested for species-specificity
initially using DNA from P. falciparum, P. vivax, P. ovale and P.
malariae.Nocross-reactivitywasobservedwiththesespecies(Figure2
and data not shown) as there was no amplification of these DNA.
Second, the primers were tested for specificity against 5 different
simian malaria parasites (P. simiovale, P. inui, P. cynomolgi, P. hylobati
and P. coatneyi) and strains thereof. Primer set Pkr140-3 produced
non-specificbandswithP.inui,P.cynomolgi,andP.hylobati(Figure3A)
and primer set Pkr140-4 with P. cynomolgi (Figure 3B). These two
primersetswerenotevaluatedfurther.PrimersetPkr140-5(Table1)
detected only the three P. knowlesi isolates (H, Nuri, and Hackeri)
used in this study (Figure 3C) and did not amplify DNA from any of
the eleven P. vivax isolates tested (Figure 4).
Further test for specificity using clinical samples
Forty two DNA specimens extracted from clinical samples
previously confirmed by PCR as positive for malaria (14 P.
falciparum,9P. vivax,1P. malariae,1 2P. ovale, 2 P. falciparum/P.
malariae, 1 P. vivax/P. ovale, 2 P. falciparum/P. ovale mixed infections,
1 P. knowlesi) and 10 malaria negative clinical samples were further
used to test the specificity of primer set Pkr140-5 in a blinded
manner. This primer set correctly identified the single sample with
known P. knowlesi infection [35] and did not show any cross-
reactivity with any of the other samples.
Limits of detection of primer set Pkr140-5
Using known quantities of P. knowlesi-H DNA, both the
previously published P. knowlesi primers and the novel Pkr140-5
Table 1. Sequence of the novel Pkr140-5 primer set.
Primer Sequence
Forward 59- CAGAGATCCGTTCTCATGATTTCCATGG -39
Reverse 59- CTRAACACCTCATGTCGTGGTAG-39
The primers were designed to target Pkr140, which is present in 7 copies
distributed across 6 different chromosomes in the available genome sequence.
doi:10.1371/journal.pone.0031848.t001
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blood with the novel primer set showing better resolution than the
previously published primer set (Figure 5).
Characteristics of Pkr140
The Pkr140 sequence repeats are present in 7 copies
distributed across 6 chromosomes (Figure 6). Six of the copies
Figure 2. Primer Pkr140-5 tested with the 4 human-infecting malaria species. To test the specificity of the novel primers, DNA from the four
additional human-infecting Plasmodium parasites were tested. P. knowlesi (H strain) was used as a positive control (expected size=200bp). A no
template control (NTC) was also included.
doi:10.1371/journal.pone.0031848.g002
Figure 3. Specificity of the P. knowlesi primers tested using simian-infecting malaria species. To test the specificity of the P. knowlesi
primers, 5 different simian-infecting malaria parasite species (P. simiovale, P. inui, P. cynomolgi, P. hylobati and P. coatneyi) including 3 different P.
knowlesi isolates were tested. The no template control (NTC) was included as a negative control. A; primer set Pkr140-3 (expected size=230bp), B;
primer set Pkr140-4 (expected size=280bp) and C; primer set Pkr140-5 (expected size=200bp). Circles indicate non-specific amplification.
doi:10.1371/journal.pone.0031848.g003
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end of chromosome 5) is truncated (only 42 bps) and is not
amplified by primer set Pkr140-5. We previously identified
repetitive sequence targets in P. falciparum and P. vivax that were
distributed to subtelomeric regions or to contigs thought to
belong to subtelomeric regions [33]. In contrast, the Pkr140
sequences are found both near chromosome ends and interior
regions. The Pkr140 sequences do not appear to be protein-
encoding and they have not been annotated as serving any
particular function. Moreover, searches of PlasmoDB (http://
plasmodb.org) did not reveal any possible function for these
sequences. Interestingly, 5 of the 7 Pkr140 repeat sequences
(including the truncated copy) are located near genes that encode
the SICAvar antigen, a member of one of the main variant gene
families in P. knowlesi [36,37].
Discussion
In this study, we report a new PCRassay based on novel genomic
target sequences for P. knowlesi detection. We have previously
reported on the use of a bioinformatics method to mine parasite
genome sequences in search of species-specific and multi-copy
sequences that can be used to design diagnostic PCR primers for
malaria detection [33]. Using this genome-mining approach, 14
primer sets were designed and tested for their utility for P. knowlesi
detection in a non-nested PCR assay. Three sets of primers were
found to amplify P. knowlesi consistently. However, two of these sets
produced non-specific bands with some simian malaria parasites
and were not tested further as our goal was to identify primers that
specifically amplify P. knowlesi. We identified primer set Pkr140-5 as
specific for the detection of P. knowlesi as it did not detect any other
Figure 4. Primer set Pkr140-5 does not cross react with P. vivax. Multiple P. vivax strains were tested using primer set Pkr140-5 (expected size
200bp) in order to test the primers’ specificity. NTC=No template control.
doi:10.1371/journal.pone.0031848.g004
Figure 5. Limits of detection of primer set Pkr140-5. The analytical sensitivity of primer set Pk140-5 (A) and the primers from a published study
[3] (B) were determined using a well-quantitated P. knowlesi DNA standard. The blood sample was serially diluted ten-fold with a starting parasitemia
of 100,000p/ml to 1p/ml. The expected base pair sizes for the two primers are included. Three different experiments are shown.
doi:10.1371/journal.pone.0031848.g005
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tested, including the closely related species P. inui and P. cynomolgi.
Previously identified diagnostic targets in P. falciparum and P. vivax
[33] were distributed at chromosome ends or unassembled contigs
belonging to chromosome ends. Subtelomeric regions in these
species have been shown (to varying degrees) to be enriched for
species-specific and multi-copy genes [38] and genes involved in
antigen variation [39,40]. The P. knowlesi genome organization
differsfrom P. falciparum and P.vivax withgenesinvolved inantigenic
variation distributed across chromosomes and not concentrated at
their ends. Given this difference in genome organization, and the
proximity of the identified Pkr140 targets to SICAvar genes, it is
perhaps not surprising that the targets are also distributed across
both chromosome ends and interiors. Based on the results from
three Plasmodium species, regions near multi-gene families are
potentially rich areas for the mining of diagnostic targets.
Our data, reported here, further confirms a previous report of
cross reactivity between 18S ribosomal RNA gene primers [3] and
P. vivax parasites. In addition, our results demonstrate that the 18S
ribosomal RNA gene primers also cross-react with at least four
simian malaria parasites (P. inui, P. hylobati, P. cynomolgi, and P.
coatneyi). The difficulty of P. knowlesi diagnosis with the 18S
ribosomal RNA gene-based PCR assay was also recently
highlighted in a study in which 2 samples determined to be
positive for P. knowlesi could not be confirmed by DNA sequencing
analysis [41]. The primer set described here showed 100%
specificity and no cross reactivity observed with any of the non- P.
knowlesi samples tested. In addition, this primer set showed a limit
of detection of 1 parasite/mL which was shown to be comparable
to the limits of detection of the previously described nested PCR
test [3]. This is promising as the primer set can be used for the
detection of low parasite levels without the need to perform a
nested PCR. A limitation of the current study is the fact that only
one clinical P. knowlesi sample was available for use to test the novel
primer sets; however, three P. knowlesi strains obtained from
monkeys were included to validate the specificity. Given the fact
that the occurrence of human P. knowlesi is a pretty novel
phenomenon that is rather confined mainly in Southeast Asia, it
was not immediately possible to evaluate a large number of P.
knowlesi samples. Therefore, further validation of these primers in
regions known to have P. knowlesi transmission will be required to
test their utility for P. knowlesi diagnosis. However, the lack of a
large sample size does not negate the fact that these primers are
indeed specific and sensitive to detect P. knowlesi.
Molecular tools for P. knowlesi detection have been reported
including nested PCR assays, two real-time PCR assays and a loop
mediated isothermal amplification (LAMP) assay [30–32,42]. The
PCR test described here does not require nested amplification,
simplifying the performance of the reaction and saving on costs.
The LAMP assay holds potential for use in regions with limited or
fewer resources, as it does not necessitate the use of expensive
thermal cyclers. The real-time PCR assays’ use is limited to
settings with real-time PCR capabilities such as reference labo-
ratories. It remains to be determined if these different assays vary
in their sensitivity and specificity to diagnose P. knowlesi infection in
field/clinical settings.
Human P. knowlesi infections have been mostly reported in
Southeast Asia [1–15]. Recently, several imported cases in other
parts of the world have also been reported [20–22,43] including
the United States [35]. The novel non-nested PCR assay described
in this study is a suitable alternative for the accurate diagnosis of P.
knowlesi by PCR in most laboratories. However, additional
laboratory and field-based testing of this assay will be necessary
to validate its utility for clinical diagnosis of P. knowlesi.
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